0000892251-20-000004.txt : 20200130 0000892251-20-000004.hdr.sgml : 20200130 20200130105419 ACCESSION NUMBER: 0000892251-20-000004 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20200129 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20200130 DATE AS OF CHANGE: 20200130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC CENTRAL INDEX KEY: 0000794172 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 310888197 STATE OF INCORPORATION: OH FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-14902 FILM NUMBER: 20560117 BUSINESS ADDRESS: STREET 1: 3471 RIVER HILLS DR CITY: CINCINNATI STATE: OH ZIP: 45244 BUSINESS PHONE: 5132713700 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 FORMER COMPANY: FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 8-K 1 form8k012920.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 29, 2020
graphic
Meridian Bioscience, Inc.
(Exact Name of Registrant as Specified in Charter)

Ohio
000-14902
31-0888197
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
 
(IRS Employer Identification No.)

3471 RIVER HILLS DRIVE, CINCINNATI, Ohio
 45244
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code (513) 271-3700

(Former Name or Former Address, if Changed Since Last Report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
     
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, no par value
VIVO
NASDAQ Global Market

 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17CFR §240.12b-2).

Emerging growth company ☐

 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act □

Item 5.07   Submission of Matters to a Vote of Security Holders.

The following matters were submitted to a vote of shareholders at the Company's Annual Meeting of Shareholders held on January 29, 2020:
 
(a)   Votes regarding the election of eight directors:

 Name
 For
 Withheld
Broker Non-Votes
 
 
 
 
 James M. Anderson
31,635,801
1,609,632
4,304,946
 Dwight E. Ellingwood
31,756,289
1,489,144
4,304,946
 Jack Kenny
32,465,539
779,894
4,304,946
 John C. McIlwraith
31,831,658
1,413,775
4,304,946
 David C. Phillips
31,197,145
2,048,288
4,304,946
 John M. Rice, Jr.
32,672,263
573,170
4,304,946
 Catherine A. Sazdanoff
31,961,596
1,283,837
4,304,946
 Felicia Williams
32,434,594
810,839
4,304,946

(b)   Votes regarding the ratification of the Audit Committee's appointment of Grant Thornton LLP as the Company's Independent Registered Public Accountants for fiscal 2020:

 For
 Against
 Abstain
36,059,628
1,468,388
22,363

 (c)   Advisory votes regarding named executive officer compensation:

For 
 Against
 Abstain
 Broker Non-Votes
26,451,821
6,627,003
166,609
4,304,946




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
MERIDIAN BIOSCIENCE, INC.
Date:  January 30, 2020
 
 
 
 
By: /s/ Bryan T. Baldasare
 
 
Executive Vice President and Chief Financial Officer
 
 
(Principal Financial and Accounting Officer)

 
 EX-101.SCH 2 vivo-20200129.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 vivo-20200129_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Amendment Flag City Area Code Entity Address, City or Town Entity Address, Country Document Period End Date Entity Incorporation, State or Country Code Entity Information, Former Legal or Registered Name Local Phone Number Entity Address, Postal Zip Code Entity Address, State or Province Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Entity Registrant Name Entity Central Index Key Entity Tax Identification Number Document Fiscal Year Focus Document Fiscal Period Focus Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Entity File Number Entity Emerging Growth Company EX-101.PRE 4 vivo-20200129_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 5 image00026.jpg begin 644 image00026.jpg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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} JSON 7 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8k012920.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "form8k012920.htm" ] }, "labelLink": { "local": [ "vivo-20200129_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "vivo-20200129_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "vivo-20200129.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "vivo", "nsuri": "http://meridianbioscience.com/20200129", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form8k012920.htm", "contextRef": "c20200129to20200129", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://meridianbioscience.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "form8k012920.htm", "contextRef": "c20200129to20200129", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationFormerLegalOrRegisteredName": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Former Legal or Registered Name of an entity", "label": "Entity Information, Former Legal or Registered Name" } } }, "localname": "EntityInformationFormerLegalOrRegisteredName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://meridianbioscience.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 8 R1.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Document and Entity Information
Jan. 29, 2020
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 29, 2020
Entity Registrant Name Meridian Bioscience, Inc.
Entity Incorporation, State or Country Code OH
Entity File Number 000-14902
Entity Tax Identification Number 31-0888197
Entity Address, Address Line One 3471 RIVER HILLS DRIVE
Entity Address, City or Town CINCINNATI
Entity Address, State or Province OH
Entity Address, Postal Zip Code 45244
City Area Code 513
Local Phone Number 271-3700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000794172
Title of 12(b) Security Common Stock
Trading Symbol VIVO
Security Exchange Name NASDAQ
ZIP 9 0000892251-20-000004-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000892251-20-000004-xbrl.zip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end EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( ,E6/E ?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ R58^4"?HAPZ" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " #)5CY0#N9YT>T K @ $0 &1O8U!R;W!S+V-O M&ULS9+!2L0P$(9?17)O)VG50^CFHGA2$%Q0O(5D=C?8I"$9:??M;>-N M%]$'\)B9/]]\ ].9*,V0\#D-$1,YS%>3[T.6)F[8@2A*@&P.Z'6NYT28F[LA M>4WS,^TA:O.A]P@-Y[?@D;35I&$!5G$E,M59(TU"34,ZX:U9\?$S]05F#6"/ M'@-E$+4 II:)\3CU'5P "XPP^?Q=0+L22_5/;.D .R6G[-;4.([UV);?)K^W=_?:!J88WO.*B:OE6<'ES+7G[OKC^ M\+L(^\&ZG?O'QF=!U<&ONU!?4$L#!!0 ( ,E6/E"97)PC$ 8 )PG 3 M >&PO=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S M:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N M+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E'S/X M%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53" MQ,!J9S]6:\?1TDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@ MX_%X.+;+THMP' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMH MG J-6T_3:W?=TXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2 M%;7E0-,@ %AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9R MG9 %#@ WQ-%,4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S M>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,B MUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C? MC8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SCFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1 MVC?"J_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE M"0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ MZK:4OK4F.$KTL@'37[]EUVY".E,%.70[@:0KX#;;J= MW#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B M(>ZAAIC/PT.'>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)5 M8#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6Q MP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>; MG*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4< M!A87,N10[I*0!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E M$A2*L P%(1=RX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TSU#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+? M.7#;.MX#7N83+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4 MJUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5 MBZPYC0IO0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%0 M2P,$% @ R58^4-25-["C @ DPL !@ !X;"]W;W)KIWO1%").\MTVGU^G%F/XYR_3A(EJNGV0O.OOE M)%7+C>VJYFY%HQ,&X$-R^;N)%-(V+9.?Q=PR:3IJ.^-C^ MB/[%+]XN9L^U>)'-G_IH+NMTF29'<>+7QKS*^U!( 4 M $\O'NA TPN27GAZ^4 O@OEA1$D+E*1 B>BS0 CYK3 C!28(?HB$,"()2TP M)P7FB+X*!#""Y;3"@E188#X+) A(),]+4F*)^6&B"4@DTRM28H7Y8:H)2"37 M+*?ME.,(8;HI3"3A+&):AB.$.2'I04)G)0 FU[P)8NPEU,8,KPH,P> MRBE7KO[@ZEQW.ME+8RLS7S^=I#3"QLN?K,$OMD*>.HTX&==<(8,2<"/G.I*6>"LCJ*1YL5=&B2 M*I/JH&P=(H.)@51PZ(K:XSNV8LP>*LCN><)@FJMO'S#A@L%,6&6T@K8'B_!YO("' M<#*)8%0':Q M)<&M'P16.@<&7+Z++K=>JWPUD11CS+=25+71;WN-5MNUAO.[XL8P@8'2%-?Z MV$%=1D4RX90;+C;PA/4K3I(R9*Y8@R)),;C'O<1]PPV>K==V-A8XU#I'\/]\ M3L*.4Z8V12)?E'PUVR+QC(A]!7J(Y JE"9%W!X_,PN%XN^UNX+6M^5YR@TLA MU^#Y[U&ULU55;B]4P$/XK(3_ G';9!:4MZ,*"H+*PY\'7M)VV M@=Q,I\=V?[U)T]O1!_'@@[XT,]],OOERF33K<9+PT@$@&974?4X[1/N.L;[J M0/'^C;&@?:0Q3G'TKFM9;QWPN@^3E&3IZ?3 %!>:%ID>U)/"GE1FT)C3$V5% MUAB](WN]*Z32=.7D&?PF1Q3Y/UBML M'9^2])[N$^;!%RF-J\%M91*Z0D4FH0ERG&B[,**Q+ 01C?)&+7AK-)\UK#,6 MP]-6(.5+.,*OS17WV)"8\[$.QT""BM7TJU[,>%S1"?Q'MLA]H+V_B998<3'X M8?"KT;/_;3 (SPX:,<[^V&SU/3NW5D[OI6BU@KB6WQ9,;BQ89'RM0SKCQ*OG M"S>E\@ X2B[@4%1'Y+OC]@PCKK=I;&[5G/Z'FO_V/K>@P7%Y%.VO_K^\RW^B MF"W=>&%S.F7\/#*JS[9^]33(R_] W[%[^?6 MT/!!XG-8\1S,Z6Y_"B]-\K!EG3>*G.[V9ZC%H-[.!?>_1/$#4$L#!!0 ( M ,E6/E 6;2-_0P$ #P" / >&PO=V]R:V)O;VLN>&ULC5'+;L(P$/P5 MRQ_0!-0B%1$NI0^DJD6EXNXD&[+"C\C>0,O7=^THA=YZLG=V/#L[7IRN \N=QGFCB$N_ST+G0=6A!2"CLVF>SS*CT,KE M8M3:^.RZ< 05H;,,1F"'< J7?BR%8L(1/E59R%P*U9-[0DW@5XK@V;N^0[LO MY$2*!GV@;9R=F 8M&CQ#G:K0NM.+\WAVEI3>5MYIG5[%1GK$$\(OL@-/6/TA MDBH_%'LMY"QGP2,&+%$C?1MZV(LXL8M9X>?(#;^N M)\GXZ+:&!BW4;SP@,,XA5!LOXI%TIK=WDWL.N]?Z@;%W^^I4TH\:X\ *A0V$LZ&8O:3RKC>LG^Z&JP MLFAEC1"'X17FP?+)K=$U'AZS@>S'G10R/'1Y?,5'W M])=9SUZ",*V'O\E$_37 ZM=E7U!+ P04 " #)5CY0"X_8 R$! !7! M$P %M#;VYT96YT7U1Y<&5S72YX;6RU5$U/PS ,_2M3KVC-X, !;;L 5Y@$ M?R D;ALU7[*]T?U[W&Y#8BIB:-LEB?/L]UX2*_/W;0::=,%'6A0-BVD1[1#K=$Y8(?LBAQF6ZD81B\MP)"\G>HA"4"G6"PG%A'TO=ZP80 MG85_64M5Y0S89-9!2DK*"-I2 \#!E]1H!/O&Z&*]][O2R"\Z"+'JO/J14%[/ M!V\]C!L8D$LJL[0%C$D-P&Z\/4OPT TF(4PS"HKL1HXGEE:"DNH3+WE$Z%O' M@CU)7*BO]["?"=MA/7;AWR"I83KOUO]H=)G+H%W\ST K @ $0 @ &9 0 9&]C4')O<',O8V]R92YX;6Q0 M2P$"% ,4 " #)5CY0F5R<(Q & "<)P $P @ &U @ M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( ,E6/E#4E3>PHP( ),+ M 8 " ?8( !X;"]W;W)K&PO&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " #) M5CY0"X_8 R$! !7! $P @ &U$@ 6T-O;G1E;G1?5'EP =97-=+GAM;%!+!08 "@ * ( " '% ! end XML 12 form8k012920_htm.xml IDEA: XBRL DOCUMENT 0000794172 2020-01-29 2020-01-29 false 0000794172 8-K 2020-01-29 Meridian Bioscience, Inc. OH 000-14902 31-0888197 3471 RIVER HILLS DRIVE CINCINNATI OH 45244 513 271-3700 false false false false Common Stock VIVO NASDAQ false XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 1 95 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://meridianbioscience.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports form8k012920.htm vivo-20200129.xsd vivo-20200129_lab.xml vivo-20200129_pre.xml image00026.jpg http://xbrl.sec.gov/dei/2019-01-31 true false XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; }